AnalystsRichard LawRichard Law's Stock Forecasts
AnalystsRichard Law
Sectors:
Industries:
Analyst Ranking
Top 28%
#1263 out of 4563 analysts
Average Return
+4.57%
Win Rate
19%4 out of 21
Risk vs Reward
Poor
Good
Richard Law's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Olema Pharmaceuticals IncOLMA | +234.19% | $3.89 | $13.00 | 2023-03-10 - 2024-03-08 | Buy |
Olema Pharmaceuticals IncOLMA | +204.17% | $4.56 | $13.87 | 2023-02-22 - 2024-02-21 | Buy |
Arvinas IncARVN | +46.97% | $31.98 | $47.00 | 2023-02-24 - 2024-02-23 | Buy |
Arvinas IncARVN | +31.90% | $24.67 | $32.54 | 2023-05-08 - 2024-04-24 | Buy |
Richard Law Analyst Color
Get additional color on Richard Law's coverage of popular stocks
Richard Law's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mineralys Therapeutics IncMLYS | 5 | Strong Buy | $30.00 | +164.08% | Initiates Coverage On | 24 days ago |
Olema Pharmaceuticals IncOLMA | 4 | Strong Buy | $24.00 | +136.45% | Initiates Coverage On | 24 days ago |
Rocket Pharmaceuticals IncRCKT | 1 | Hold | $39.00 | +65.04% | Initiates Coverage On | 24 days ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Hold | $62.00 | +46.12% | Initiates Coverage On | 24 days ago |
Monte Rosa Therapeutics IncGLUE | 4 | Hold | $11.00 | +101.10% | Reiterates | 8 months ago |
Verve Therapeutics IncVERV | 2 | Hold | $31.00 | +371.12% | Reiterates | 8 months ago |
Beam Therapeutics IncBEAM | 3 | Hold | $47.00 | +106.68% | Maintains | 9 months ago |
Crispr Therapeutics AgCRSP | 6 | Hold | $63.00 | +13.21% | Maintains | 9 months ago |
Kymera Therapeutics IncKYMR | 8 | Hold | $37.00 | +5.08% | Maintains | 9 months ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $76.00 | +259.00% | Reiterates | 10 months ago |
Q32 Bio IncQTTB | 4 | Hold | $36.00 | +35.39% | Reiterates | a year ago |
Editas Medicine IncEDIT | 3 | Hold | $14.00 | +161.68% | Maintains | a year ago |
Arvinas IncARVN | 4 | Buy | $61.00 | +87.46% | Reiterates | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.